Systemic cytomegalovirus infection in an immunocompetent adolescent
DOI:
https://doi.org/10.32818/reccmi.a8n1a3Keywords:
cytomegalovirus, immunocompetent, colitis, severe infectionAbstract
Cytomegalovirus (CMV) is a DNA virus that belongs to the family of herpesvirus with the ability to remain latent in the organism after the primary infection. About 40-100% of the population are being carriers of the virus, depending on the geographical area. It is responsible for multiple clinical features in immunocompromised individuals and frequently complicates organ transplants. However, it is extremely infrequent to cause severe clinical features in immunocompetent individuals, with only a few hundred cases described in this population group in recent decades. We present the case of a fifteen-year-old teenage girl diagnosed with cytomegalovirus colitis, suffering severe clinical symptoms that required hospitalization for two weeks.
Downloads
Metrics
References
Gugliesi F, Coscia A, Griffante G, Galitska G, Pasquero S, Albano C, et al. Where do we Stand after Decades of Studying Human Cytomegalovirus? Microorganisms. 2020; 8(5): 685. doi: https://dx.doi.org/10.3390/microorganisms8050685 (último acceso dic. 2022). DOI: https://doi.org/10.3390/microorganisms8050685
Da Cunha T, Wu GY. Cytomegalovirus hepatitis in immunocompetent and immunocompromised hosts. J Clin Transl Hepatol. 2021; 9(1): 106-115. doi: https://dx.doi.org/10.14218/jcth.2020.00088 (último acceso dic. 2022). DOI: https://doi.org/10.14218/JCTH.2020.00088
Fakhreddine AY, Frenette CT, Konijeti GG. A practical review of Cytomegalovirus in gastroenterology and hepatology. Gastroenterol Res Pract. 2019; 2019: 6156581. doi: https://dx.doi.org/10.1155/2019/6156581 (último acceso dic. 2022). DOI: https://doi.org/10.1155/2019/6156581
Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008; 5(1): 47. Accesible en: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC2289809 (último acceso dic. 2022). DOI: https://doi.org/10.1186/1743-422X-5-47
Liu K-Y, Chao H-M, Lu Y-J, Su Y-S, Lee W-S. Cytomegalovirus proctitis in non-human immunodeficiency virus infected patients: A case report and literature review. J Microbiol Immunol Infect [Internet]. 2022; 55(1): 154–60. doi: https://dx.doi.org/10.1016/j.jmii.2021.10.002 (último acceso dic. 2022). DOI: https://doi.org/10.1016/j.jmii.2021.10.002
Friel, TJ. Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent adults In: UpToDate, Hirsch MS, Bond S (Eds), UpToDate, Waltham, MA, 2022. Accesible en: https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-treatment-of-cytomegalovirus-infection-in-immunocompetent-adults?search=treatment%20cmv&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H20 (último acceso dic. 2022).
Fernández-Ruiz M, Muñoz-Codoceo C, López-Medrano F, Faré-García R, Carbonell-Porras A, Garfia-Castillo C, et al. Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult; successful treatment with oral valcangiclovir. Intern Med. 2008; 47(22): 1963-6. Accesible en: https://www.jstage.jst.go.jp/article/internalmedicine/47/22/47_22_1963/_pdf/-char/en (último acceso dic. 2022). DOI: https://doi.org/10.2169/internalmedicine.47.1480
Knipe DM, Howley PM, et al. Fields Virology Sixth Edition, Chapter 62 | Cytomegaloviruses; pag. 1997. Philadelphia (EEUU), Ed. Lippincott Williams & Williams (Wolters Kluwer). 2013.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Diego Rivas-Otero, Julia Carmona-González, Carmen Suárez-Huelga, Manuel de Pablo-Casas
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
